Interferon-alpha therapy in atopic dermatitis.

Authors

  • A Torrelo
  • A Harto
  • E Sendagorta
  • B M Czarnetzki
  • A Ledo

DOI:

https://doi.org/10.2340/0001555572370372

Abstract

Thirteen patients with a severe adult form of atopic dermatitis (AD) received 3.0 x 10(6) IU of recombinant interferon-alpha 2a (rIFN-alpha 2a) 3 times a week. A satisfactory response was obtained in 5 of them. Serum IgE levels in all 13 patients remained unchanged throughout the study. Flu-like symptoms were common, but clinical or laboratory adverse effects were otherwise slight. The moderately beneficial therapeutic effects observed in this study support a possible role for IFN-alpha in controlling immunologic deficiencies in atopic dermatitis.

Downloads

Download data is not yet available.

Downloads

Published

1992-09-01

How to Cite

Torrelo, A., Harto, A., Sendagorta, E., Czarnetzki, B. M., & Ledo, A. (1992). Interferon-alpha therapy in atopic dermatitis. Acta Dermato-Venereologica, 72(5), 370–372. https://doi.org/10.2340/0001555572370372

Issue

Vol. 72 No. 5 (1992)

Section

Articles

License

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC